shortagewatch

Home / Companies / AA Pharma

Company family · HQ CA

AA Pharma: medicine shortages

private

As of 2 Nov 2026, 46 AA Pharma products have a reported shortage across 1 countries, covering 26 medicines.

Products short46rank #38 of 464
Medicines26active ingredients
Countries1/16
New in 90 days17+17 vs market pace
Typical duration11 monthsmedian so far
Manufacturing100%demand-driven 0%

Where

Canada46

Which therapeutic classes

Nervous system29Anti-infectives4Cardiovascular system4Sensory organs4Respiratory system2Genito-urinary system and sex hormones1Musculoskeletal system1Blood1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
AA PharmaAA Pharma: Manufacturing problem 39 (85%)85%AA Pharma: Not stated 7 (15%)15%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

When its current shortages began

025710Dec: 1Jan ’25: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 1Nov: 0NovDec: 1Jan ’26: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 1AugSep: 10Oct: 6Nov: 0Nov

Long-run trend in Canada

Canada dashboard
02550751002017: 2320172018: 2720182019: 3320192020: 1620202021: 3920212022: 4220222023: 6420232024: 7820242025: 4620252026: 5620262027: 22027

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158AA Pharma46

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7AA Pharma: 46 / 26AA Pharma

Further right: more products short. Higher: more different medicines affected.

Medicines short

MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Amitriptyline1229 Nov 2023Not stated5/16
Trifluoperazine515 Mar 2019Manufacturing problem2/16
Lorazepam331 Dec 2026Manufacturing problem5/16
Chlordiazepoxide215 Aug 2023Manufacturing problem3/16
Ketorolac27 Oct 2025Manufacturing problem1/16
Telmisartan and Amlodipine223 Feb 2022Manufacturing problem3/16
Adefovir Dipivoxil130 Jun 2022Manufacturing problem1/16
Amiloride115 Sep 2026Manufacturing problem2/16
Brimonidine18 Sep 2026Manufacturing problem4/16
Bromocriptine18 Sep 2026Manufacturing problem2/16
Diazepam11 Sep 2026Manufacturing problem7/16
Ipratropium Bromide113 Oct 2026Manufacturing problem2/16
Ipratropium Bromide125 Aug 2026Manufacturing problem1/16
Levodopa and Decarboxylase Inhibitor16 Oct 2026Manufacturing problem4/16
Medroxyprogesterone129 Sep 2026Manufacturing problem1/16
Mefenamic Acid16 Oct 2026Manufacturing problem4/16
Methazolamide127 Oct 2026Manufacturing problem1/16
Methyldopa (Racemic)119 Oct 2026Manufacturing problem1/16
Minocycline129 Sep 2026Manufacturing problem3/16
Norfloxacin122 Sep 2026Manufacturing problem3/16
Nortriptyline115 Sep 2026Manufacturing problem2/16
Prochlorperazine122 Sep 2026Manufacturing problem2/16
Temazepam18 Sep 2026Manufacturing problem1/16
Tetracycline115 May 2019Manufacturing problem2/16
Ticlopidine128 Feb 2019Manufacturing problem3/16
Trihexyphenidyl16 Oct 2026Manufacturing problem2/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.